Announcement under Regulation 30 (LODR)-Change in Management
Filed with BSE · · 3 pages · English
Summary by 6ix AI
Asston Pharmaceuticals Limited has filed a notification regarding changes in management and financial approvals following their recent annual general meeting. The company has approved the re-appointment of its Managing Director and the appointment of new statutory auditors. Additionally, there are increases in remuneration for several directors, including the Managing Director and the Whole-time Director.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Asston Pharmaceuticals Limited on 6ix
Earlier from Asston Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Asston Pharmaceuticals Limited Press Release Sep 29 2026
- Asston Pharmaceuticals Limited Press Release Sep 27 2026
- Asston Pharmaceuticals Limited Press Release Sep 07 2026
Later from Asston Pharmaceuticals
- Board Meeting Intimation for To Consider And Approve The Following Matters As Attached
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Asston Pharmaceuticals into a list and get an email when it puts out news.
Follow Asston Pharmaceuticals